- Home
- SONN vs RELI Comparison
SONN vs RELI Comparison
Compare SONN & RELI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SONN
- RELI
- Stock Information
- Founded
- SONN N/A
- RELI 2013
- Country
- SONN United States
- RELI United States
- Employees
- SONN N/A
- RELI N/A
- Industry
- SONN Biotechnology: Pharmaceutical Preparations
- RELI Specialty Insurers
- Sector
- SONN Health Care
- RELI Finance
- Exchange
- SONN Nasdaq
- RELI Nasdaq
- Market Cap
- SONN 3.8M
- RELI 3.5M
- IPO Year
- SONN N/A
- RELI N/A
- Fundamental
- Price
- SONN $3.99
- RELI $1.30
- Analyst Decision
- SONN Strong Buy
- RELI
- Analyst Count
- SONN 1
- RELI 0
- Target Price
- SONN $20.00
- RELI N/A
- AVG Volume (30 Days)
- SONN 11.6M
- RELI 235.7K
- Earning Date
- SONN 08-13-2025
- RELI 08-05-2025
- Dividend Yield
- SONN N/A
- RELI N/A
- EPS Growth
- SONN N/A
- RELI N/A
- EPS
- SONN N/A
- RELI N/A
- Revenue
- SONN $1,000,000.00
- RELI $14,208,143.00
- Revenue This Year
- SONN $5,376.22
- RELI N/A
- Revenue Next Year
- SONN N/A
- RELI N/A
- P/E Ratio
- SONN N/A
- RELI N/A
- Revenue Growth
- SONN 978.39
- RELI 2.40
- 52 Week Low
- SONN $1.08
- RELI $0.97
- 52 Week High
- SONN $19.30
- RELI $5.11
- Technical
- Relative Strength Index (RSI)
- SONN 47.24
- RELI 40.97
- Support Level
- SONN $4.16
- RELI $1.41
- Resistance Level
- SONN $19.30
- RELI $1.54
- Average True Range (ATR)
- SONN 1.98
- RELI 0.11
- MACD
- SONN -0.41
- RELI -0.04
- Stochastic Oscillator
- SONN 1.03
- RELI 13.73
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
About RELI Reliance Global Group Inc.
Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing acquisition strategies, initially and focused on wholesale and retail insurance agencies. Its primary strategies is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.